These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37944029)

  • 1. Targeting anti-CXCR3 autoantibodies as potential cardioprotective therapy: promises and challenges.
    Tang WHW
    Eur Heart J; 2023 Dec; 44(47):4950-4952. PubMed ID: 37944029
    [No Abstract]   [Full Text] [Related]  

  • 2. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL9 and its Receptor CXCR3, an Important Link Between Inflammation and Cardiovascular Risks in RA Patients.
    Shamsi A; Roghani SA; Abdan Z; Soufivand P; Pournazari M; Bahrehmand F; Vafaei A; Salari N; Soroush MG; Taghadosi M
    Inflammation; 2023 Dec; 46(6):2374-2385. PubMed ID: 37542661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory antibodies against GPCR in women ten years after early-onset preeclampsia.
    Birukov A; Muijsers HEC; Heidecke H; Drost JT; Cunnigham MW; Kraker K; Haase N; Frolova A; Müller DN; Herse F; Maas AHEM; Dechend R
    Front Biosci (Landmark Ed); 2019 Jun; 24(8):1462-1476. PubMed ID: 31136991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren's syndrome.
    Yue X; Deng F; Chen J; Yin J; Zheng J; Chen Y; Huang Q; Gao X; Liu Z; Luo J; Müller A; Heidecke H; Riemekasten G; Petersen F; Yu X
    Mol Immunol; 2021 Mar; 131():112-120. PubMed ID: 33446393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases.
    Altara R; Manca M; Brandão RD; Zeidan A; Booz GW; Zouein FA
    Clin Sci (Lond); 2016 Apr; 130(7):463-78. PubMed ID: 26888559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis.
    Segerer S; Banas B; Wörnle M; Schmid H; Cohen CD; Kretzler M; Mack M; Kiss E; Nelson PJ; Schlöndorff D; Gröne HJ
    Am J Pathol; 2004 Feb; 164(2):635-49. PubMed ID: 14742268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
    Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y
    Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic challenges and cardiovascular risk in patients with HMGCR-associated immune-mediated necrotizing myopathy (HMGR-IMNM) secondary to statins.
    Álvarez-Troncoso J; Molina SC; Robles-Marhuenda Á; Martínez-Robles E; Ríos-Blanco JJ
    Eur J Intern Med; 2023 Aug; 114():143-145. PubMed ID: 37179139
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.
    Cabral-Marques O; Halpert G; Schimke LF; Ostrinski Y; Vojdani A; Baiocchi GC; Freire PP; Filgueiras IS; Zyskind I; Lattin MT; Tran F; Schreiber S; Marques AHC; Plaça DR; Fonseca DLM; Humrich JY; Müller A; Giil LM; Graßhoff H; Schumann A; Hackel A; Junker J; Meyer C; Ochs HD; Lavi YB; Scheibenbogen C; Dechend R; Jurisica I; Schulze-Forster K; Silverberg JI; Amital H; Zimmerman J; Heidecke H; Rosenberg AZ; Riemekasten G; Shoenfeld Y
    Nat Commun; 2022 Mar; 13(1):1220. PubMed ID: 35264564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors.
    Weng Y; Siciliano SJ; Waldburger KE; Sirotina-Meisher A; Staruch MJ; Daugherty BL; Gould SL; Springer MS; DeMartino JA
    J Biol Chem; 1998 Jul; 273(29):18288-91. PubMed ID: 9660793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
    Balashov KE; Rottman JB; Weiner HL; Hancock WW
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.
    Weigold F; Günther J; Pfeiffenberger M; Cabral-Marques O; Siegert E; Dragun D; Philippe A; Regensburger AK; Recke A; Yu X; Petersen F; Catar R; Biesen R; Hiepe F; Burmester GR; Heidecke H; Riemekasten G
    Arthritis Res Ther; 2018 Mar; 20(1):52. PubMed ID: 29566745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
    Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
    Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization.
    Loetscher M; Loetscher P; Brass N; Meese E; Moser B
    Eur J Immunol; 1998 Nov; 28(11):3696-705. PubMed ID: 9842912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart.
    Altara R; Mallat Z; Booz GW; Zouein FA
    J Immunol Res; 2016; 2016():4396368. PubMed ID: 27795961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes.
    Aust G; Sittig D; Steinert M; Lamesch P; Lohmann T
    Clin Exp Immunol; 2002 Mar; 127(3):479-85. PubMed ID: 11966764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines.
    Cockwell P; Calderwood JW; Brooks CJ; Chakravorty SJ; Savage CO
    Nephrol Dial Transplant; 2002 May; 17(5):734-44. PubMed ID: 11981057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of chemokine receptors in vernal keratoconjunctivitis.
    Abu El-Asrar AM; Struyf S; Al-Mosallam AA; Missotten L; Van Damme J; Geboes K
    Br J Ophthalmol; 2001 Nov; 85(11):1357-61. PubMed ID: 11673306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.